Autism is the most common and impactful childhood disease with ramifications for the child, their future, parents and caregivers, and society as a whole. Grosvenor et al notes:
Innate Vitality Vitami...
Buy New $17.99 ($0.20 / Count)
(as of 02:07 UTC - Details)
Autism spectrum disorder (ASD) is a neurodevelopmental condition diagnosed by the presence of social communication impairments and restricted and repetitive behaviors.1 The lifelong presentation of ASD often co-occurs with multiple physical and mental health conditions leading to diverse health service utilization and high annual medical costs…Hypothesized reasons for prevalence increases include changes to developmental screening practices diagnosis definitions, policies, and environmental factors as well as increased advocacy and education.
The leading environmental factor under consideration is the rapidly intensifying routine ACIP CDC childhood vaccine schedule, where children are recommended to receive up to 27 vaccines by age 2. Vaccines given in combination can raise levels of neuroinflammatory cytokines, induce a vaccine febrile seizure, and trigger the onset of autism spectrum disorder.
CNN recently interviewed vaccine-advocate Dr. Paul Offit, who told the public that there’s no link between vaccines and autism, and that “it’s amazing we still talk about this.” However, the data presented below suggest otherwise.
Dr. Paul Offit: “There were seven misstatements of fact within three-and-a-half minutes. I’m not sure what the record is, but that has to be close.” pic.twitter.com/FsRxdN3Y57
— Kaitlan Collins (@kaitlancollins) November 1, 2024
Grosevenor et al examined annual ASD diagnosis rates in health records of patients in US health systems (n = 12,264,003) from January 1, 2011, to December 31, 2022 and found that ASD diagnosis rates increased substantially between 2011 and 2022, particularly among young adults, female children and adults. The ASD diagnosis rate increased by 175% among the full study sample, from 2.3 per 1000 in 2011 to 6.3 per 1000 in 2022. Among 0-to-4-year-olds, autism diagnosis rates skyrocketed by 352%, from 6.4 per 1000 persons in 2011 to 28.8 per 1000 persons in 2022.
However, the authors did not look for the underlying causes behind this disturbing increase. In the United States, the CDC recommends all children to receive the ‘7-vaccine series’ by age 2, which includes diphtheria-tetanus-acellular pertussis, inactivated poliovirus, measles-mumps-rubella, hepatitis B, Haemophilus influenzae type b, varicella, and pneumococcal conjugate vaccinations. The CDC uses the ‘7-vaccine series’ as the main combined measure for surveillance of multiple vaccinations in early childhood.
Newcomer et al, also recently published in JAMA, found among 179,154 US children (derived from the nationally representative 2011 to 2021 National Immunization Survey–Child), that completion of the combined 7-vaccine series by age 19 months increased from 52.2% (95% CI, 50.8%-53.5%) in the 2011 survey to 59.4% (95% CI, 57.9%-60.9%) in the 2021 survey. Further analysis revealed that the prevalence of on-time receipt of the combined 7-vaccine series increased from 22.5% (95% CI, 21.4%-23.6%) to 35.6% (95% CI, 34.2%-37.0%). As the authors note,
“In contrast to vaccination coverage, assessment of vaccination timeliness provides a more direct measure of adherence to national recommendations for the ages when children should receive vaccinations.”
(click to enlarge)
These data reveal a concerning correlation between increased ASD diagnosis rates, particularly among ages 0-4, and increased childhood 7-vaccine series uptake by age 19 months. This is consistent with a comprehensive study by Delong (1% increase in vaccination was associated with an additional 680 children having autism or speech impairment), Dr. Andrew Wakefield’s seminal observation, large numbers of anecdotal reports from parents whose children regressed into ASD shortly after vaccination complicated by a febrile seizure, along with CDC whistleblower data from Dr. William Thompson.
Of great concern is a battery of sixteen vaccines (including a monoclonal antibody and mRNA COVID-19 products) given around 12-15 months and the observation that a severe febrile seizure could result in sudden infant death syndrome or the development of a neuropsychiatric disorder such as autism.
(click to enlarge)
Autism prevalence in the US continues to skyrocket and currently stands at 1 in 36 kids, up 317% since 2000. Global vaccine coverage has been increasing over time since 1980. Immediate action is required by our regulatory authorities to investigate this crisis before we reach a tipping point where a substantial minority of children have ASD.
The Lethal Dose: Why Y...
Best Price: $12.89
Buy New $7.99
(as of 08:32 UTC - Details)
Nicolas Hulscher, MPH
Epidemiologist and Foundation Administrator, McCullough Foundation
Peter A. McCullough, MD, MPH
President, McCullough Foundation
www.mcculloughfnd.org
Newcomer SR, Michels SY, Albers AN, et al. Vaccination Timeliness Among US Children Aged 0-19 Months, National Immunization Survey–Child 2011-2021. JAMA Netw Open. 2024;7(4):e246440. doi:10.1001/jamanetworkopen.2024.6440
This originally appeared on Courageous Discourse.
